• Initiated collaborations with senior executives of multi-national pharma that generated strategic alliances ventures • Overseeing tech scouting for international pharma and their digital health units to support strategic needs, in-licensing, partnership and /or investment• Established academic relation and collaboration with Technology Transfer Offices (TTOs) in top research institutions (Israel and Canada) to source innovative translational opportunities• Managed multiple due diligence (market evaluations, regulation, IP and working with KOLs) for investments

• Facilitated the translation of academic life science and medical device research projects from Ariel University • Identified and shaped high impact collaborative research and pilot activities• Performed technology scouting, scientific evaluation, market analysis, IP and commercialization strategies and pro-active marketing • Led of negotiations towards license agreements and/or spin-off establishment • Managed projects and established Research & License agreements ($5M), Research Services and MTAs. • Raised $1.5M R&D funding from the Israel Innovation Authority (IIA)• Part of a team that established and manages an Ariel-Assuta Research Cooperation (2ARC) to conduct translational medical research activities • Establishing partnerships with leading Chinese universities to promote commercial development of biomedical technologies

• Led a team of researchers to identify mechanisms involved in Alzheimer’s Disease• Developed novel drugs (patent pending), recovering cognitive defects in mouse models of Alzheimer’s disease • Developed and executed on patent strategy with the technology transfer office of Columbia University to secure intellectual property protection for our discoveries, while marketing discoveries to potential industry partners

• Managed a company that aimed to commercialize drug discoveries for the treatment of Alzheimer’s and orphan diseases from our lab at Columbia University• Responsible for all aspects of company operations, including business development, strategy and finance • Formed collaborations that generated promising preliminary data for the treatment of Huntington disease • Performed due diligence on Contract Research Organizations (CROs)• Directed CRO projects, securing data necessary to proceed to preclinical trials